Critical

Percutaneous mechanical circulatory support

MCS devices · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Temporary mechanical circulatory support devices (intra-aortic balloon pump, Impella, VA-ECMO) unload the ventricle and maintain systemic perfusion in refractory cardiogenic shock as a bridge to recovery, decision or definitive therapy. Device selection depends on the degree of support needed, the failing ventricle and the need for oxygenation.

Red flags

  • Rising lactate despite maximal support (inadequate device flow)
  • Limb ischaemia at the cannulation site
  • LV distension / pulmonary oedema on VA-ECMO
  • Device thrombosis or haemolysis
  • Uncontrolled bleeding on anticoagulation

Assessment

Differential diagnosis

  • Acute MI cardiogenic shock
  • Fulminant myocarditis
  • Decompensated cardiomyopathy
  • Post-cardiotomy shock
  • Massive PE with RV failure
  • Refractory arrhythmic shock

Investigations

  • Echocardiography (ventricular function, valves, tamponade)
  • Coronary angiography where ischaemic
  • Lactate and end-organ perfusion markers
  • Cardiac output / haemodynamic monitoring
  • ABG (oxygenation needs guide device)
  • Vascular access assessment (peripheral arterial disease)

Management

  • Confirm refractory cardiogenic shock despite inotropes/vasopressors and identify the dominant failing ventricle and whether oxygenation support is needed
  • Treat the underlying cause in parallel (revascularise MI, anticoagulate/reperfuse PE)
  • Choose device by support requirement: IABP for modest afterload reduction/coronary augmentation; Impella for direct LV unloading and higher flow; VA-ECMO for biventricular failure or when oxygenation support is required
  • For isolated RV failure consider a dedicated RV support device or VA-ECMO
  • Insert with specialist/cardiology input and vascular access planning; confirm position on imaging
  • Set and titrate device support to perfusion targets while weaning catecholamines
  • Anticoagulate per device protocol and monitor closely
  • On VA-ECMO watch for LV distension and consider venting/unloading (e.g. adding Impella - ECPELLA) to protect the lung and heart
  • Monitor for limb ischaemia with femoral cannulae; consider a distal perfusion cannula
  • Monitor haemolysis, bleeding, device position and end-organ recovery daily
  • Define goals of support early (bridge to recovery, transplant, VAD, or decision) with the heart team
  • Plan weaning as ventricular function recovers, with echo-guided support reduction

Drugs & doses

Unfractionated heparin infusion titrated to device-specific targets
Noradrenaline / adrenaline to maintain perfusion while weaning
Dobutamine or milrinone for residual inotropy
Platelet/factor support for device-related bleeding as needed

Disposition

Cardiac ICU at a centre with cardiology, cardiac surgery and ECMO capability; early heart-team involvement for exit strategy.

Complications & pitfalls

  • Limb ischaemia and compartment syndrome
  • Bleeding and haemolysis
  • Thromboembolism / stroke
  • LV distension and pulmonary oedema (VA-ECMO)
  • Device malposition or failure
  • Infection

Exam pearls

  • Match the device to the problem: IABP for modest support, Impella for LV unloading, VA-ECMO for biventricular failure or when oxygenation is needed
  • VA-ECMO can distend the LV - watch for pulmonary oedema and consider venting (ECPELLA)
  • Femoral VA-ECMO/Impella risks limb ischaemia - monitor the distal limb and place a perfusion cannula
  • Define the exit strategy (bridge to what) before or at the time of implantation

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.